Sandra Weil

Sandra Weil is currently the Project Head of Innovation at Sanofi, where they have held various roles since 2018, including Laboratory Head for Engineered Antibodies and Protein Therapeutics. Prior to this, Sandra worked as a Wissenschaftlicher Mitarbeiter (Postdoktorand) and Wissenschaftliche Mitarbeiterin (Doktorandin) at Universitätsmedizin Mainz from 2016 to 2017. They also spent six years at the Chemotherapeutisches Forschungszentrum "Georg-Speyer-Haus," serving as a Wissenschaftliche Mitarbeiterin (Doktorandin). Sandra earned a Dr. rer. nat. in Biology from Technische Universität Darmstadt and a Diplom in Biochemistry from Johann Wolfgang Goethe-Universität Frankfurt am Main, both completed in 2010.